Grufity logoGrufity logo

Xylem Inc Stock Research

XYL

102.40USD+0.92(+0.91%)Market Closed

Market Summary

USD102.40+0.92
Market Closed
0.91%

XYL Alerts

XYL Stock Price

XYL RSI Chart

XYL Valuation

Market Cap

18.5B

Price/Earnings (Trailing)

51.98

Price/Sales (Trailing)

3.34

EV/EBITDA

29.14

Price/Free Cashflow

30.96

XYL Price/Sales (Trailing)

XYL Profitability

Operating Margin

37.74%

EBT Margin

7.97%

Return on Equity

10.16%

Return on Assets

4.46%

Free Cashflow Yield

3.23%

XYL Fundamentals

XYL Revenue

Revenue (TTM)

5.5B

Revenue Y/Y

13.83%

Revenue Q/Q

9.13%

XYL Earnings

Earnings (TTM)

355.0M

Earnings Y/Y

31.86%

Earnings Q/Q

1.1K%

Price Action

52 Week Range

71.65118.58
(Low)(High)

Last 7 days

5.0%

Last 30 days

-0.2%

Last 90 days

-7.4%

Trailing 12 Months

17.4%

XYL Financial Health

Current Ratio

1.89

XYL Investor Care

Dividend Yield

1.17%

Dividend/Share (TTM)

1.2

Shares Dilution (1Y)

0.01%

Diluted EPS (TTM)

1.96

Peers (Alternatives to Xylem)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
73.2B
15.9B
2.88% 13.29%
24.11
4.59
10.22% 12.62%
23.2B
5.9B
-1.27% 12.95%
38.39
3.92
14.83% 7.50%
18.5B
5.5B
-0.24% 17.36%
51.98
3.34
6.29% -16.86%
17.1B
3.2B
0.88% 17.28%
29.16
5.38
15.09% 30.60%
12.0B
2.1B
3.18% 2.14%
26.12
5.61
7.84% 4.72%
MID-CAP
7.9B
3.4B
1.98% 21.97%
22.14
2.31
10.23% 12.47%
7.0B
3.0B
-7.00% 9.63%
19.05
2.34
8.05% 16.03%
4.4B
3.6B
-3.06% -3.60%
23.3
1.22
2.09% 49.85%
SMALL-CAP
1.2B
125.6M
0.18% 8.12%
51.56
9.87
20.87% 68.54%
633.8M
521.0M
-12.81% -32.20%
56.62
1.22
37.72% -62.50%
131.4M
254.5M
-10.95% -42.15%
14.25
0.52
9.95% 139.59%
104.2M
273.9M
1.17% -29.72%
-21.25
0.38
29.46% -7.17%
43.0M
491.1M
-46.74% -65.73%
-3.16
0.09
1.00% -108.69%

Financials for Xylem

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue3.4%5,5225,3395,2245,2115,195
Cost Of Revenue3.1%3,4383,3353,2723,2593,220
Gross Profit4.0%2,0842,0041,9521,9521,975
  S&GA Expenses1.2%1,2271,2131,1921,1821,179
  R&D Expenses1.0%206204206206204
EBITDA11.7%601538667679-
EBITDA Margin8.0%0.11*0.10*0.13*0.14*-
Earnings Before Taxes16.7%440377493495511
EBT Margin12.8%0.08*0.07*0.09*0.10*-
Interest Expenses0%50.0050.0059.0068.0076.00
Net Income11.3%355319421422427
Net Income Margin7.6%0.06*0.06*0.08*0.08*-
Free Cahsflow31.3%596454364483-
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-1.9%7,9528,1068,1898,2198,276
  Current Assets-5.6%3,0123,1913,1743,1183,160
    Cash Equivalents-20.4%9441,1861,1131,1171,349
  Inventory-4.5%799837852804700
  Net PPE7.7%630585608636644
  Goodwill3.1%2,7192,6372,7142,7822,792
Liabilities-8.9%4,4494,8844,9865,0135,050
  Current Liabilities-17.6%1,5901,9291,9511,9201,391
    LT Debt, Non Current0%1,8801,8801,8791,8782,440
Shareholder's Equity8.7%3,4943,2153,2033,2063,218
  Retained Earnings4.3%2,2922,1972,2382,1812,154
  Additional Paid-In Capital0.5%2,1342,1232,1112,0992,089
Shares Outstanding0.0%180180180--
Minority Interest28.6%9.007.008.008.008.00
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations31.3%596454364483538
  Share Based Compensation2.8%37.0036.0034.0033.0033.00
Cashflow From Investing1.0%-191-193-198-195-183
Cashflow From Financing-205.0%-790-259-851-846-855
  Dividend Payments1.4%217214211207203
  Buy Backs0%52.0052.0052.0052.0068.00

Risks for XYL

What is the probability of a big loss on XYL?

55%


Probability that Xylem stock will be more than 20% underwater in next one year

37.7%


Probability that Xylem stock will be more than 30% underwater in next one year.

12.3%


Probability that Xylem stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does XYL drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Xylem was unfortunately bought at previous high price.

Drawdowns

Returns for XYL

Cumulative Returns on XYL

15.6%


10-Year Cumulative Returns

15.4%


7-Year Cumulative Returns

7.1%


5-Year Cumulative Returns

16.9%


3-Year Cumulative Returns

What are the long-term rolling returns for XYL?

FIve years rolling returns for Xylem.

Annualized Returns

Which funds bought or sold XYL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-29
Diametric Capital, LP
sold off
-100
-1,334,000
-
-%
2023-03-23
MetLife Investment Management, LLC
reduced
-1.64
1,044,810
5,311,560
0.04%
2023-03-23
ETF MANAGERS GROUP, LLC
added
4.22
224,346
928,346
0.04%
2023-03-17
American Portfolios Advisors
unchanged
-
4,968
47,274
-%
2023-03-15
B. Riley Wealth Advisors, Inc.
added
24.2
533,264
1,467,260
0.04%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
2.88
75,977,200
327,482,000
0.36%
2023-03-10
BAILLIE GIFFORD & CO
added
6.19
89,099,300
348,102,000
0.36%
2023-03-08
Capital Asset Advisory Services LLC
reduced
-18.92
27,695
652,695
0.05%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-13.16
749,000
8,296,000
0.04%
2023-03-03
TIAA, FSB
new
-
204,776
204,776
-%

1–10 of 47

Latest Funds Activity

Are funds buying XYL calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own XYL
No. of Funds

Xylem News

MarketBeat

Hartford Investment Management Co. Sells 4171 Shares of Xylem ....

MarketBeat,
4 hours ago

Seeking Alpha

Nasdaq

Marketscreener.com

Marketscreener.com

Zacks Investment Research

Here's Why Xylem (XYL) is a Strong Growth Stock.

Zacks Investment Research,
10 days ago

Schedule 13G FIlings of Xylem

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
aristotle capital management, llc
5.59%
10,076,810
SC 13G/A
Feb 09, 2023
vanguard group inc
11.67%
21,037,631
SC 13G/A
Jan 24, 2023
blackrock inc.
11.2%
20,207,719
SC 13G/A
Feb 14, 2022
aristotle capital management, llc
5.89%
10,627,194
SC 13G/A
Jan 27, 2022
blackrock inc.
10.0%
18,052,578
SC 13G/A
Jan 26, 2022
blackrock inc.
10.0%
18,052,578
SC 13G/A
Feb 16, 2021
price t rowe associates inc /md/
0.5%
944,169
SC 13G/A
Feb 10, 2021
vanguard group inc
10.35%
18,653,103
SC 13G/A
Feb 02, 2021
aristotle capital management, llc
5.03%
9,073,140
SC 13G
Jan 27, 2021
blackrock inc.
10.1%
18,252,469
SC 13G/A

XYL Fair Value

Xylem fair value in different scenarios

The table shows the Fair Value estimates for Xylem for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

24.53

-76.04%

31.68

-69.06%

43.60

-57.42%

65.37

-36.16%

81.39

-20.52%
Current Inflation

21.00

-79.49%

24.68

-75.90%

35.23

-65.60%

56.42

-44.90%

69.53

-32.10%
Very High Inflation

20.75

-79.74%

25.66

-74.94%

33.30

-67.48%

47.79

-53.33%

58.14

-43.22%

Historical Xylem Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Xylem

View All Filings
Date Filed Form Type Document
Mar 15, 2023
4
Insider Trading
Mar 13, 2023
144
Notice of Insider Sale Intent
Mar 10, 2023
4
Insider Trading
Mar 09, 2023
3
Insider Trading
Mar 09, 2023
4
Insider Trading
Mar 09, 2023
S-4
Mergers and Acquisition
Mar 03, 2023
4
Insider Trading
Mar 03, 2023
4
Insider Trading
Mar 03, 2023
4
Insider Trading
Mar 03, 2023
4
Insider Trading

Latest Insider Trading transactions for XYL

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-13
Decker Patrick
acquired
2,072,330
36.81
56,298
president & ceo
2023-03-13
Decker Patrick
sold
-5,527,840
98.1889
-56,298
president & ceo
2023-03-09
ELLIS EARL RAY
acquired
-
-
249
-
2023-03-07
Toussaint Claudia S
gifted
-
-
-4,977
svp, cpso
2023-03-02
Yarkadas Hayati
sold
-1,601,010
100
-15,942
svp & president, eu, wi & gls
2023-03-02
Yarkadas Hayati
acquired
823,117
74.0813
11,111
svp & president, eu, wi & gls
2023-03-01
Pine Matthew Francis
sold (taxes)
-80,265
101
-794
coo
2023-03-01
Yarkadas Hayati
acquired
-
-
4,204
svp & president, eu, wi & gls
2023-03-01
Yarkadas Hayati
sold (taxes)
-10,311
101
-102
svp & president, eu, wi & gls
2023-03-01
Decker Patrick
sold (taxes)
-558,219
101
-5,522
president & ceo

1–10 of 50

Patrick K. Decker
17300
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, Leopold, Wedeco, and Xylem Vue brand names for the transportation and treatment of water. The Applied Water segment provides pumps, valves, heat exchangers, controls, and dispensing equipment systems under the Goulds Water Technology, Bell & Gossett, A-C Fire Pump, Standard Xchange, Lowara, Jabsco, Xylem Vue and Flojet brand names for residential and commercial building services, and industrial water applications. The Measurement & Control Solutions segment provides smart meters, networked communication devices, and measurement and control technologies, as well as critical infrastructure technologies. It also offers software and services, including cloud-based analytics, remote monitoring and data management, leak detection, condition assessment, asset management, and pressure monitoring solutions, as well as testing equipment and managed services. This segment sells its products under the Pure, Sensus, Smith Blair, WTW, Xylem Vue, and YSI brand names. The company markets and sells its products through a network of direct sales force, resellers, distributors, and value-added solution providers. Xylem Inc. was formerly known as ITT WCO, Inc. and changed its name to Xylem Inc. in May 2011. The company. was incorporated in 2011 and is headquartered in Rye Brook, New York.

XYL Income Statement

2022-12-31
Consolidated Income Statements - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Revenue$ 5,522$ 5,195$ 4,876
Cost of revenue3,4383,2203,046
Gross profit2,0841,9751,830
Selling, general and administrative expenses1,2271,1791,143
Research and development expenses206204187
Restructuring and asset impairment charges29775
Goodwill, Impairment Loss0058
Operating income622585367
Interest expense507677
U.K. pension settlement expense(140)00
Other non-operating income (expense), net70(5)
Gain on sale of businesses120
Income before taxes440511285
Income tax expense858431
Net income$ 355$ 427$ 254
Earnings per share:   
Basic (in dollars per share)$ 1.97$ 2.37$ 1.41
Diluted (in dollars per share)$ 1.96$ 2.35$ 1.40
Basic (in shares)180,217180,247180,116
Weighted average common shares outstanding — Diluted180,979181,526181,099
Dividends declared per share (in usd per share)$ 1.20$ 1.12$ 1.04

XYL Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 944$ 1,349
Receivables, less allowances for discounts, returns and credit losses of $50 and $44 in 2022 and 2021, respectively1,096953
Inventories799700
Prepaid and other current assets173158
Total current assets3,0123,160
Property, plant and equipment, net630644
Goodwill2,7192,792
Other intangible assets, net9301,016
Other non-current assets661664
Total assets7,9528,276
Current liabilities:  
Accounts payable723639
Accrued and other current liabilities867752
Total current liabilities1,5901,391
Long-term debt, net1,8802,440
Accrued post-retirement benefit obligations286438
Deferred income tax liabilities222287
Other non-current accrued liabilities471494
Total liabilities4,4495,050
Commitment and Contingencies (Note 19)
Common stock — par value $0.01 per share:  
Authorized 750.0 shares, issued 196.0 and 195.6 shares in 2022 and 2021, respectively22
Capital in excess of par value2,1342,089
Retained earnings2,2922,154
Treasury stock – at cost 15.8 shares and 15.2 shares in 2022 and 2021, respectively(708)(656)
Accumulated other comprehensive loss(226)(371)
Total stockholders’ equity3,4943,218
Non-controlling interest98
Total equity3,5033,226
Total liabilities and stockholders’ equity$ 7,952$ 8,276